Vous êtes ici
Onglets principaux
Profil
Ana Cristina Andreazza
Affiliation
University of TorontoAcadémie ou Collège
Collège de nouveaux chercheurs et créateurs en art et en scienceAnnée d'admission
2021Website URL
https://www.mito2i.caDomaines d’expertise
My research focuses on understanding the role of mitochondrial function on brain health. Mitochondria are the powerhouse of our cells, they are responsible for generating energy to enable our organs and muscles to perform their tasks, for example neurotransmission, the way our brain cells communicate.
As neurons depend on mitochondrial function, dysfunctional mitochondrial is expected to have crucial implications for mood disorders. My goal is to develop diagnostics methods that can identify patients with mood disorders that suffer from mitochondrial dysfunction and develop strategies to prevent and treat it.
Diagnosing and treating mitochondrial dysfunction early in the disease will lead to avoid unnecessary years of suffering of ineffective treatments and development of severe comorbidities such as metabolic syndrome, cardiovascular disease, and diabetes.
Ana Andreazza is a Professor of Pharmacology and Psychiatry at University of Toronto. She holds a Canada Research Chair in Molecular Pharmacology of Mood Disorder and the Thomas C. Zachos Chair in Mitochondrial Research. Her research focuses on the effects of mitochondrial dysfunction on neurotransmission phenotypes, to unveil the brain’s mitochondrial signatures and advance discovery of novel and effective treatments for complex brain illnesses.
Ana Andreazza est professeure de pharmacologie et de psychiatrie à l'Université de Toronto. Elle est titulaire d'une chaire de recherche du Canada en pharmacologie moléculaire des troubles de l'humeur et de la chaire Thomas C. Zachos en recherche mitochondriale. Ses recherches se concentrent sur les effets du dysfonctionnement mitochondrial sur les phénotypes de neurotransmission complexes, afin de dévoiler les signatures mitochondriales du cerveau et faire avancer la découverte de traitements nouveaux et efficaces pour les maladies cérébrales complexes.